IMDZ - Immune Design Corp. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - IMDZ (1437786)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
12 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2019-01-07
IMDZPaya Carlos VPres, CEOS - Sale+OE$1.58-13,014156,576-8%-$20,591
D
2019-01-07
IMDZTer Meulen Jan HenrikChief Scientific OfficerS - Sale+OE$1.59-3,41483,982-4%-$5,415
D
2019-01-07
IMDZYurasov SergeySVP, Clinic. Devel., CMOS - Sale+OE$1.57-3,52278,756-4%-$5,536
D
2019-01-07
IMDZBrady Stephen REVP, Strategy, FinanceS - Sale+OE$1.58-5,51696,599-5%-$8,722
2018-12-04
IMDZBvf Partners L P/il10%S - Sale$1.83-902,000370,391-71%-$1,653,907
A
2018-01-08
IMDZGuthart Leo10%P - Purchase$3.90+20,0005,664,7390%+$78,000
D
2018-01-05
IMDZGombotz WayneChief Development OfficerS - Sale+OE$4.17-1,98637,068-5%-$8,282
D
2018-01-05
IMDZPaya Carlos VPres, CEOS - Sale+OE$4.17-7,970106,590-7%-$33,247
D
2018-01-05
IMDZTer Meulen Jan HenrikChief Scientific OfficerS - Sale+OE$4.17-1,98639,034-5%-$8,282
D
2018-01-05
IMDZBrady Stephen REVP, Strategy, FinanceS - Sale+OE$4.17-3,32847,162-7%-$13,885
A
2018-01-05
IMDZYurasov SergeySVP, Clinic. Devel., CMOS - Sale$4.17-67527,325-2%-$2,816
D
2018-01-04
IMDZYurasov SergeySVP, Clinic. Devel., CMOS - Sale+OE$4.17-67527,325-2%-$2,816
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top